COMPARISON BETWEEN WAIST AND HIP RATIO LEVELS IN HEALTHY WOMEN AND PATIENTS WITH POLYCYSTIC OVARY SYNDROME

Vesko Stoilov, Ivan Kostov, Petar Petrov, Ivo Dimitrov

Abstract


In analyzing the results we found that the largest number of patients in the control group had waist and hip ratio (WHR) values in the range of 0.75-0.8 or 40.09% of all. Second in the same group are women with a WHR of 0.8-0.85 (29.70%) who can be identified as high-risk according to the current World Health Organization (WHO) criteria. Third are women with WHR above 0.9 (10.89%).

Analyzing the results in women with Polycystic ovary syndrome (PCOS), we found that the highest number of them had values of the studied indicator between 0.85-0.9 or a total of 40.39% of all, who can be defined as high risk according to WHO. The second largest group is that of women with WHR above 0.8-0.85 (30.04%). Third is the group of women with WHR values above 0.9 (18.22%) who are considered to be at the highest risk of developing cardiovascular and metabolic complications.

Keywords


index, waist, hips

Full Text:

PDF

References


Robeva R., Nyakoi nevroendokrinni aspekti na gonadnite narusheniya pri sastoyaniya na insulinova rezistentnost, Disertatsionen trud, Sofiya 2008.

Ardaems Y et al. PCOD: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis, 1991;55, 1062-1068.

Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP (June 1986). Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45 (5): 685– 98.

Behringer RR (1994). 5 The in Vivo Roles of Müllerian-inhibiting Substance. The in vivo roles of müllerian-inhibiting substance. Curr. Top. Dev. Biol. Current Topics in Developmental Biology 29: 171–87

Hampl, R.; Šnajderová, M.; Mardešić, T. (2011). Antimüllerian hormone (AMH) not only a marker for prediction of ovarian reserve. Physiological research / Academia Scientiarum Bohemoslovaca 60 (2): 217–223.

Imbeaud S, Faure E, Lamarre I, Mattéi MG, di Clemente N, Tizard R, Carré-Eusèbe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart JM, Lababidi A, Josso N, Cate RL, Picard JY (December 1995). Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor. Nat. Genet. 11 (4): 382–8.

Walter F., PhD. Boron (2003). Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. p. 1300. ISBN 1-4160-2328-3.

An Introduction to Behavioral Endocrinology, Randy J Nelson, 3rd edition, Sinauer

Kelsey TW, Wright P, Nelson SM,Anderson RA, Wallace WHB (2011). A validated model of serum anti-Müllerian hormone from conception to menopause. In Vitzthum, Virginia J. PLoS ONE 6 (7): e22024. doi:10.1371/journal.pone.0022024. PMC 3137624. PMID 21789216.


Refbacks

  • There are currently no refbacks.


New knowledge Journal of science Jubilee edition is financed by the National Science Fund of the Republic of Bulgaria – contract № ДНП 05/52 от 22.12.2016 in the competition of Bulgarian scientific periodicals – 2016

The contents of this publication do not necessarily reflect the position or opinion of the National Science Fund of the Republic of Bulgaria. The opinions expressed are those of the author(s) only and should not be considered as representative of the National Science Fund’s official position.

https://www.fni.bg/

National Science Fund of Bulgaria